ASND
Ascendis Pharma AS
227.30$
-0.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.7% | +21.3% | +8.4% | +19.9% | +660.1% | +41.2% | +62.9% | +16.7% | +5.3% | -6.3% | -4.0% | |
| – | +34.5% | +327.4% | +32.6% | +102.4% | +90.7% | +41.8% | +25.7% | -4.0% | +3.9% | +43.3% | +21.6% | |
| – | – | – | +543.3% | -149.0% | – | +343.5% | -100.4% | – | – | – | – | |
| – | – | – | +23.4% | -66.0% | +138.6% | -123.7% | – | – | – | – | – | |
| – | +156.5% | -35.3% | +40.0% | +181.4% | +94.8% | +317.8% | +12.4% | -40.2% | -83.1% | -41.6% | +471.1% | |
| – | +156.5% | -35.3% | +40.0% | +181.4% | +94.8% | +5,544.5% | -62.0% | – | +364.1% | -97.6% | -218.5% | |
| – | – | – | – | – | – | – | – | -84.7% | – | – | – | |
| – | -17.3% | +10.4% | +5.7% | +62.6% | +144.6% | -100.0% | – | +387.4% | -98.3% | -100.0% | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +18.2% | +34.7% | – | -74.7% | -2.4% | -117.9% | |
| – | +120.7% | +11.1% | +6.2% | +63.0% | +142.8% | +22.1% | -41.7% | +12.9% | -66.2% | +230.6% | -92.1% | |
| – | +126.1% | -12.7% | -75.2% | +449.3% | +288.1% | -104.2% | – | – | – | – | -26.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.